BE843505A - Pyrrolidones et medicaments qui en contiennent - Google Patents

Pyrrolidones et medicaments qui en contiennent

Info

Publication number
BE843505A
BE843505A BE168390A BE168390A BE843505A BE 843505 A BE843505 A BE 843505A BE 168390 A BE168390 A BE 168390A BE 168390 A BE168390 A BE 168390A BE 843505 A BE843505 A BE 843505A
Authority
BE
Belgium
Prior art keywords
pyrrolidons
products containing
medicinal products
medicinal
products
Prior art date
Application number
BE168390A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE843505A publication Critical patent/BE843505A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
BE168390A 1975-06-27 1976-06-28 Pyrrolidones et medicaments qui en contiennent BE843505A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528664 DE2528664A1 (de) 1975-06-27 1975-06-27 Pyrrolidone und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BE843505A true BE843505A (fr) 1976-12-28

Family

ID=5950059

Family Applications (1)

Application Number Title Priority Date Filing Date
BE168390A BE843505A (fr) 1975-06-27 1976-06-28 Pyrrolidones et medicaments qui en contiennent

Country Status (14)

Country Link
JP (1) JPS525764A (fr)
AT (1) AT365575B (fr)
BE (1) BE843505A (fr)
CH (1) CH623809A5 (fr)
DE (1) DE2528664A1 (fr)
DK (1) DK287476A (fr)
ES (1) ES449095A1 (fr)
FR (1) FR2316943A1 (fr)
GB (1) GB1553595A (fr)
IL (1) IL49916A0 (fr)
LU (1) LU75235A1 (fr)
NL (1) NL7606773A (fr)
SE (1) SE7607331L (fr)
ZA (1) ZA763802B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1077948A (fr) * 1976-08-06 1980-05-20 Albin J. Nelson Production de 2-pyrrolidones disubstituees en 1,5
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
AU1293101A (en) * 1999-12-22 2001-07-03 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
CA2429850C (fr) 2000-11-27 2008-12-30 Pfizer Products Inc. Agonistes selectifs au recepteur ep4 dans le traitement de l'osteoporose
BR0211167A (pt) 2001-07-16 2004-08-10 Hoffmann La Roche Derivados de 2-pirrolidona como agonistas de prostanóides
KR20040015364A (ko) 2001-07-16 2004-02-18 에프. 호프만-라 로슈 아게 Ｅｐ4 수용체 작용물질로서의 프로스타글란딘 유사체
MXPA04000757A (es) 2001-07-23 2004-07-08 Ono Pharmaceutical Co Remedios para enfermedades con perdida de masa de hueso que tienen agonistas ep4 como ingrediente activo.
JP2005531516A (ja) * 2002-03-18 2005-10-20 ファイザー・プロダクツ・インク 選択的ｅｐ４受容体アゴニストによる治療方法
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
CA2511255C (fr) 2003-01-10 2009-04-07 F. Hoffmann-La Roche Ag Derives de 2-piperidone agonistes de la prostaglandine
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
CA2879506C (fr) 2012-07-19 2020-10-27 Cayman Chemical Company, Inc. Compositions de difluorolactame destinees a des maladies et des affections osseuses mediees par ep4
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CA2903314C (fr) 2013-03-15 2023-02-14 Cayman Chemical Company, Inc. Procedes de synthese d'un analogue difluorolactam
EA201591793A1 (ru) 2013-03-15 2016-01-29 Кайман Кемикал Компани, Инк. Лактамные соединения в качестве селективных агонистов ep4-рецепторов для применения при лечении опосредованных ep4 заболеваний и состояний
EP3021879A2 (fr) 2013-07-19 2016-05-25 Cayman Chemical Company, Incorporated Procédés, systèmes et compositions pour activer la croissance osseuse

Also Published As

Publication number Publication date
NL7606773A (nl) 1976-12-29
DE2528664A1 (de) 1977-01-13
FR2316943A1 (fr) 1977-02-04
AT365575B (de) 1982-01-25
ES449095A1 (es) 1977-12-16
ZA763802B (en) 1977-05-25
JPS525764A (en) 1977-01-17
DK287476A (da) 1976-12-28
IL49916A0 (en) 1976-08-31
FR2316943B1 (fr) 1978-11-03
GB1553595A (en) 1979-09-26
ATA467976A (de) 1981-06-15
SE7607331L (sv) 1976-12-28
CH623809A5 (en) 1981-06-30
LU75235A1 (fr) 1977-03-16

Similar Documents

Publication Publication Date Title
BE846335R (fr) (polyalcoxy-phenyl)-4-pyrrolidinones-2 et medicaments qui en contiennent
BE860877A (fr) Spirolactones steroidiques et medicaments qui en contiennent
FR2282892A1 (fr) Derives de la purine et medicaments qui en contiennent
BE861451A (fr) Phenyl-5 oxazolidines et thiazolidines, et medicaments qui en contiennent
FR2295739A1 (fr) Oxo-20 homopregnanes et medicaments qui en contiennent
BE865870A (fr) Derives du benzimidazole et medicaments qui en contiennent
FR2316943A1 (fr) Pyrrolidones et medicaments qui en contiennent
FR2312240A1 (fr) Derives du prostane et medicaments qui en contiennent
FR2326927A1 (fr) Steroides insatures en 15 et medicaments qui en contiennent
BE849788A (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
FR2281123A1 (fr) Oxo-20 pregnanes et medicaments qui en contiennent
BE852089A (fr) Androstenones et medicaments qui en contiennent
FR2287224A1 (fr) Derives de la pyridine et medicaments qui en contiennent
DK194776A (da) Antibakterielle midler og mellemprodukter dertil
FR2287908A1 (fr) Hydroxy-7 oestradiols et medicaments qui en contiennent
BE849346R (fr) Pyrrolidones et medicaments qui en contiennent
FR2316941A1 (fr) Pyrrolidones et medicaments qui en contiennent
FR2342973A1 (fr) Azapurines et medicaments contenant ces substances
FR2307526A1 (fr) Oxo-11 prostaglandines et medicaments qui en contiennent
BE788322A (fr) 3,4-dihydro-2h-isoquinoleine-1-ones et medicaments qui en contiennent
FR2347925A1 (fr) Medicaments, cosmetiques et pesticides renfermant des fluoroacyl-resorcines
FR2343477A1 (fr) Nouvelles phenylpyridylhydantoines substituees et medicament les contenant
BE843351A (fr) Pyrrolidones et medicaments qui en contiennent
FR2283674A1 (fr) Homo-steroides et medicaments qui en renferment
FR2313066A1 (fr) Oxadiazines et medicaments qui en contiennent

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: HOECHST A.G.

Effective date: 19860630